COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,019 Articles (22,627 medRxiv, 8,392 bioRxiv)

Most recent first Previous |  Page 2222: Articles 22211-22220  | Next

Distribution equality as an optimal epidemic mitigation strategy
Hacohen, A., Cohen, R., Efroni, S., Bachelet, I., Barzel, B.
10.1101/2020.09.15.20194506 — Posted: 2020-09-18
An Application of Logistic Formula to Deaths by COVID-19 in Japan
Saito, T.
10.1101/2020.09.15.20195081 — Posted: 2020-09-18
What Does the Public Want to Know About The COVID-19 Pandemic? A Systematic Analysis of Questions Asked in The Internet
George, J., Gautham, D., Kesarwani, V., Sugumar, P. A., Malhotra, R.
10.1101/2020.09.15.20192039 — Posted: 2020-09-18
Disease control as an optimization problem
Navascues, M., Guryanova, Y., Budroni, C.
10.1101/2020.09.15.20194811 — Posted: 2020-09-18
Acute, non-COVID related medical admissions during the first wave of COVID-19: A retrospective comparison of changing patterns of disease
Riley, B., Packer, M., Gallier, S., Sapey, E., Atkin, C.
10.1101/2020.09.15.20194795 — Posted: 2020-09-18
Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: Randomized Control Trial in Singapore
Seneviratne, C. J., Balan, P., Ki, K. K. K., Udawatte, N. S., Lai, D., Lin, D. N. H., Venkatachalam, I., Lim Kheng Sit, J., Moi Lin, L., Oon, L., Goh, B. T., Sim Xiang Ying, J.
10.1101/2020.09.14.20186494 — Posted: 2020-09-18 Discussion: Onsite
Pre-existing T cell memory as a risk factor for severe 1 COVID-19 in the elderly
Bacher, P., Rosati, E., Esser, D., Rios Martini, G., Saggau, C., Schiminsky, E., Dargvainiene, J., Schröder, I., Wieters, I., Eberhardt, F., Neb, H., Khodamoradi, Y., Sonntagbauer, M., Vehreschild, M. J., Conrad, C., Tran, F., Rosenstiel, P., Markewitz, R., Wandinger, K.-P., Rybniker, J., Kochanek, M., Leypoldt, F., Cornely, O. A., Koehler, P., Franke, A., Scheffold, A.
10.1101/2020.09.15.20188896 — Posted: 2020-09-18
Pentoxifylline and Covid-19: A Systematic Review
Ramonfaur, D., Gonzalez, C. A., Paredes-Vazquez, J. G.
10.1101/2020.09.14.20194381 — Posted: 2020-09-18
Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin
Emmerich, P., Murawski, C., von Possel, R., Oestereich, L., Duraffour, S., Pahlmann, M., Struck, N. S., Eibach, D., Krumkamp, R., Amuasi, J., Maiga-Ascofare, O., Rakotozandrindrainy, R., Asogun, D., Ighodalo, Y., May, J., Tannich, E., Deschermeier, C.
10.1101/2020.09.15.20159749 — Posted: 2020-09-18
Early Release Estimates for SARS-CoV-2 Prevalence and Antibody Response Interim Weighting for Probability-Based Sample Surveys
Bradley, H., Fahimi, M., Sanchez, T., Lopman, B., Frankel, M., Kelley, C., Rothenberg, R., Siegler, A. J., Sullivan, P. S.
10.1101/2020.09.15.20195099 — Posted: 2020-09-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).